Modest proteasomal inhibition by aberrant ubiquitin exacerbates aggregate formation in a Huntington disease mouse model.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Molecular and cellular neurosciences

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.mcn.2009.12.001PMID 20005957
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology.

  2009cited by this paper
• Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin.

  2009cited by this paper
• The Ubiquitin-Proteasome Reporter GFPu Does Not Accumulate in Neurons of the R6/2 Transgenic Mouse Model of Huntington's Disease

  2009cited by this paper
• Global changes to the ubiquitin system in Huntington's disease

  2007cited by this paper
• Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease

  2007cited by this paper
• HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS

  2007cited by this paper
• Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

  2004cited by this paper
• Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases.

  2004cited by this paper
• Generalized brain and skin proteasome inhibition in Huntington's disease

  2004cited by this paper
• Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.

  2004cited by this paper
• Protein aggregation and neurodegenerative disease

  2004cited by this paper
• The mouse brain in stereotaxic coordinates

  2003cited by this paper
• Disease‐specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain

  2003cited by this paper
• Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia.

  2002cited by this paper
• Protein surveillance machinery in brains with spinocerebellar ataxia type 3: Redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions

  2002cited by this paper
• Impairment of the ubiquitin-proteasome system by protein aggregation.

  2001cited by this paper
• Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death1

  2001cited by this paper
• Differential susceptibility of cultured cell lines to aggregate formation and cell death produced by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch.

  2001cited by this paper
• Glutamine repeats and neurodegeneration.

  2000cited by this paper
• Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain.

  1999cited by this paper
• Regional specificity of brain atrophy in Huntington's disease.

  1998cited by this paper
• Reduced penetrance of the Huntington's disease mutation.

  1997cited by this paper
• Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

  1997cited by this paper
• Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias

  1995cited by this paper

• Neurodegenerative diseases: Epigenetic regulatory mechanisms and therapeutic potential.

  2025cites this paper
• The Dose-Dependent Pleiotropic Effects of the UBB+1 Ubiquitin Mutant

  2021cites this paper
• Activation of the Unfolded Protein Response and Proteostasis Disturbance in Parkinsonism-Dementia of Guam.

  2019cites this paper
• Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies

  2018cites this paper
• Different Expression Levels of Human Mutant Ubiquitin B+1 (UBB+1) Can Modify Chronological Lifespan or Stress Resistance of Saccharomyces cerevisiae

  2018cites this paper
• On protein quality control, myofibrillar myopathies, and neurodegeneration

  2017cites this paper
• The essential and downstream common proteins of amyotrophic lateral sclerosis: A protein-protein interaction network analysis

  2017cites this paper
• On protein quality control, myofibrillar myopathies, and neurodegeneration

  2017cites this paper
• On protein quality control, myofibrillar myopathies, and neurodegeneration

  2017cites this paper
• Gene therapy by proteasome activator, PA28γ, improves motor coordination and proteasome function in Huntington's disease YAC128 mice.

  2016cites this paper
• Characterizing polyubiquitinated forms of the neurodegenerative ubiquitin mutant UBB+1

  2016cites this paper
• Ubiquitin-dependent proteolysis in yeast cells expressing neurotoxic proteins

  2015cites this paper
• Hypervulnerability to Sound Exposure through Impaired Adaptive Proliferation of Peroxisomes.

  2015influential citation
• Accumulation of Basic Amino Acids at Mitochondria Dictates the Cytotoxicity of Aberrant Ubiquitin

  2015cites this paper
• Spermidine protects against α-synuclein neurotoxicity

  2014cites this paper
• Baclofen, a GABAB receptor agonist, enhances ubiquitin-proteasome system functioning and neuronal survival in Huntington's disease model mice.

  2014cites this paper
• Cellular protein quality control and the evolution of aggregates in spinocerebellar ataxia type 3 (SCA3)

  2012cites this paper
• The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?

  2012cites this paper
• Accumulation of histone deacetylase 6, an aggresome‐related protein, is specific to Lewy bodies and glial cytoplasmic inclusions

  2011cites this paper
• Pathogenic mechanisms in Huntington's disease.

  2011cites this paper
• The ubiquitin proteasome system in Huntington disease : impairment of the proteolytic machinery aggravates huntingtin aggregation and toxicity

  2011cites this paper
• On protein quality control, myofibrillar myopathies, and neurodegeneration

  year unknowncites this paper